Oxybutynin Chloride
Product Images NDC 70934-529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 70934-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 529 30 Master Bottle Label Approval Rev A 01 20)

Label (70934 529 30 Master Bottle Label Approval   Rev A 01 20)
NDC 70934-529-30 is a prescription drug available in the form of 30 tablets of Oxybutynin Chloride 5mg, used to treat certain bladder and urinary conditions.*
FDA Label Image

Graph 1 (Oxybutynin Graph1)

FDA Label Image

Graph 2 (Oxybutynin Graph2)

FDA Label Image

Structure (Oxybutynin Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.